Atrial fibrillation: Challenges and opportunities

被引：3
作者：
Hersi, Ahmad
Mitchell, L. Brent
Wyse, D. George [1 ]
机构：
[1] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada
[2] Calgary Hlth Reg, Calgary, AB, Canada
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2006年 / 22卷
关键词：
anticoagulation; arrhythmia management; atrial fibrillation; epidemiology; treatment;
D O I：
10.1016/S0828-282X(06)70998-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice. There are many pharmacological and nonpharmacological options available for AF patients. There is, however, a great deal of dissatisfaction with the available treatments of this arrhythmia. Furthermore, AF management remains associated with many challenges that make the treatment of AF a vexing problem. The present overview discusses these challenges and explores the opportunities associated with them.
引用
收藏
页码：21C / 26C
页数：6
相关论文
共 59 条
[1]  
Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690
[2]  
Albers GW, 2003, LANCET, V362, P1691
[3]   Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket'' approach [J].
Alboni, P ;
Botto, GL ;
Baldi, N ;
Luzi, M ;
Russo, V ;
Gianfranchi, L ;
Marchi, P ;
Calzolari, M ;
Solano, A ;
Baroffio, R ;
Gaggioli, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23) :2384-2391
[4]   Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction [J].
Alsheikh-Ali, AA ;
Wang, PJ ;
Rand, W ;
Konstam, MA ;
Homoud, MK ;
Link, MS ;
Estes, NAM ;
Salem, DN ;
Al-Ahmad, AM .
AMERICAN HEART JOURNAL, 2004, 147 (06) :1061-1065
[5]   Frequency of elevation of C-reactive protein in atrial fibrillation [J].
Anderson, JL ;
Maycock, CAA ;
Lappé, DL ;
Crandall, BG ;
Horne, BD ;
Bair, TL ;
Morris, SR ;
Li, QY ;
Muhlestein, JB .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (10) :1255-1259
[6]   Inflammation as a risk factor for atrial fibrillation [J].
Aviles, RJ ;
Martin, DO ;
Apperson-Hansen, C ;
Houghtaling, PL ;
Rautaharju, P ;
Kronmal, RA ;
Tracy, RP ;
Van Wagoner, DR ;
Psaty, BM ;
Lauer, MS ;
Chung, MK .
CIRCULATION, 2003, 108 (24) :3006-3010
[7]   Pharmacological cardioversion of atrial fibrillation - Current management and treatment options [J].
Boriani, G ;
Diemberger, I ;
Biffi, M ;
Martignani, C ;
Branzi, A .
DRUGS, 2004, 64 (24) :2741-2762
[8]   Genetics of cardiovascular disease with emphasis on atrial fibrillation [J].
Brugada, R ;
Brugada, J ;
Roberts, R .
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 1999, 3 (01) :7-13
[9]  
Bruins P, 1997, CIRCULATION, V96, P3542
[10]   Advances in antiarrhythmic drug treatment of atrial fibrillation: Where do we stand now? [J].
Camm, AJ ;
Savelieva, I .
HEART RHYTHM, 2004, 1 (02) :244-246
123456